HILPDA anticorps (C-Term)

N° du produit ABIN6991583

Détail du produit anti-HILPDA anticorps

Antigène: HILPDA (Hypoxia Inducible Lipid Droplet-Associated (HILPDA))

Épitope: C-Term

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp HILPDA est non-conjugé

Application: Western Blotting (WB), ELISA

Specificité: At least two isoforms of HIG2 are known to exist, this antibody will detect both isoforms. HIG2 antibody is predicted to not cross-react with HIG1

Purification: HIG2 Antibody is affinity chromatography purified via peptide column.

Immunogène: HIG2 antibody was raised against a 16 amino acid synthetic peptide near the carboxy terminus of human HIG2. The immunogen is located within the last 50 amino acids of HIG2.

Isotype: IgG

Information d'application

Indications d'application: HIG2 antibody can be used for detection of HIG2 by Western blot at 1 μ,g/mL.

Antibody validated: Western Blot in human samples. All other applications and species not yet tested.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: HIG2 Antibody is supplied in PBS containing 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,4 °C

Stockage commentaire: HIG2 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur HILPDA

Antigène: HILPDA (Hypoxia Inducible Lipid Droplet-Associated (HILPDA))

Autre désignation: HIG2 (HILPDA Produits)

Synonymes: anticorps 2310016C08Rik, anticorps AW049004, anticorps Hig2, anticorps C7orf68, anticorps HIG-2, anticorps HIG2, anticorps hypoxia inducible lipid droplet associated, anticorps Hilpda, anticorps HILPDA

Sujet: HIG2 Antibody: HIG1 and HIG2 (Hypoxia-inducible gene 1 and 2, respectively) are known to be induced by hypoxic conditions. HIG2 is induced by hypoxia and by glucose deprivation in cultured cells. In addition, tumor xenografts derived from human cervical cancer cells display increased expression of HIG1 and HIG2 when they are deprived of oxygen. Unlike HIG2, which is ubiquitously expressed and might be an activator and target of the canonical Wnt pathway, the function and the mechanisms underlying its regulation of HIG1 still remained unknown. The putative link between hypoxia and an oncogenic signaling pathway might play an important role in tumorigenesis.

ID gène: 192286

NCBI Accession: NP_001092256

UniProt: Q9BW72